Topic

Somatuline Depot (lanreotide)

A collection of 29 issues

How to Get Somatuline Depot (Lanreotide) Covered by Blue Cross Blue Shield in Florida: 2025 Prior Authorization Guide

Answer Box: Getting Somatuline Depot Covered by Florida Blue Florida Blue Cross Blue Shield requires prior authorization for Somatuline Depot (lanreotide) with 1-year approval for FDA-approved indications (acromegaly, GEP-NETs, carcinoid syndrome). Coverage criteria include documented inadequate response to octreotide, specialist oversight, and quantity limits of one syringe per 28 days.

How to Get Somatuline Depot (Lanreotide) Covered by Humana in Ohio: Complete Appeals Guide with Forms and Timelines

Quick Answer: Getting Somatuline Depot Covered by Humana in Ohio Fastest path to approval: Have your endocrinologist or oncologist submit a prior authorization request through Humana's provider portal or by calling 800-555-2546, including medical necessity documentation for your acromegaly, GEP-NET, or carcinoid syndrome diagnosis. If denied, you have

How Long Does It Take to Get Somatuline Depot (Lanreotide) Approved by Aetna CVS Health in New York? Complete Timeline Guide

Answer Box: Getting Somatuline Depot Approved by Aetna CVS Health in New York Aetna CVS Health requires prior authorization for Somatuline Depot (lanreotide) with typical processing taking 2-45 days depending on submission method and completeness. Electronic submissions via Availity process fastest (24-72 hours), while standard requests take 30-45 days. First

How to Get Somatuline Depot (Lanreotide) Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide

Quick Answer: UnitedHealthcare requires prior authorization for Somatuline Depot (lanreotide) in Pennsylvania, typically under medical benefit (HCPCS J1930) with step therapy requiring prior octreotide trial. Submit PA via UHC Provider Portal with diagnosis confirmation, prior therapy records, and specialist documentation. If denied, file internal appeals within 65 days (Medicare Advantage)

How to Get Somatuline Depot (Lanreotide) Covered by Blue Cross Blue Shield in Illinois: Complete Prior Authorization and Appeal Guide

Answer Box: Your Fast Track to Somatuline Depot Coverage Blue Cross Blue Shield of Illinois requires prior authorization for Somatuline Depot (lanreotide) for commercial members. The fastest path: Have your prescriber submit documentation of your FDA-approved diagnosis (acromegaly, GEP-NETs, or carcinoid syndrome), any failed octreotide trials, and supporting labs via

How to Get Somatuline Depot (Lanreotide) Covered by Humana in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Somatuline Depot (Lanreotide) Covered by Humana in California Fastest path: Humana requires prior authorization for Somatuline Depot, often with step therapy requiring octreotide LAR trial first. If denied, file internal appeals within 65 days, then escalate to federal Independent Review Entity (IRE) for Medicare Advantage plans or

Myths vs. Facts: Getting Somatuline Depot (lanreotide) Covered by UnitedHealthcare in Michigan

Quick Answer: Getting Somatuline Depot Covered Yes, UnitedHealthcare covers Somatuline Depot (lanreotide) in Michigan with prior authorization. Most denials stem from missing documentation or step-therapy requirements, not coverage exclusions. The fastest path: ensure your endocrinologist or oncologist documents FDA-approved indications (acromegaly, GEP-NETs, carcinoid syndrome), prior octreotide trial or contraindication, and

Work With Your Doctor to Get Somatuline Depot (Lanreotide) Approved by Aetna CVS Health in New Jersey

Answer Box: To get Somatuline Depot (lanreotide) covered by Aetna CVS Health in New Jersey, you'll need prior authorization through CVS Specialty Pharmacy with documentation of acromegaly, GEP-NET, or carcinoid syndrome diagnosis plus any required step therapy (often octreotide trial). Submit via Availity portal or fax 1-800-323-2445 with

How to Get Somatuline Depot (Lanreotide) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Blue Cross Blue Shield plans in Washington (primarily Premera Blue Cross) require prior authorization for Somatuline Depot (lanreotide), typically demanding an octreotide trial first. Submit PA with specialist documentation, FDA-approved diagnosis (acromegaly, GEP-NETs, carcinoid syndrome), and clinical failure evidence. If denied, appeal within 180 days internally, then request

Myths vs. Facts: Getting Somatuline Depot (Lanreotide) Covered by Aetna CVS Health in California

Answer Box: Getting Somatuline Depot Covered by Aetna CVS Health in California Aetna CVS Health requires prior authorization for Somatuline Depot (lanreotide) with specific criteria for acromegaly, GEP-NETs, and carcinoid syndrome. Key requirements include elevated IGF-1 levels, endocrinologist/oncologist prescription, and often prior octreotide trial. Fastest path: Submit complete PA